Compare Dr. Reddys with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB AUROBINDO PHARMA DR. REDDYS LAB/
AUROBINDO PHARMA
 
P/E (TTM) x 47.8 7.9 605.3% View Chart
P/BV x 4.6 1.9 236.9% View Chart
Dividend Yield % 0.5 0.6 93.7%  

Financials

 DR. REDDYS LAB   AUROBINDO PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
AUROBINDO PHARMA
Mar-21
DR. REDDYS LAB/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs5,5151,023 539.0%   
Low Rs3,028333 908.2%   
Sales per share (Unadj.) Rs1,145.4422.8 270.9%  
Earnings per share (Unadj.) Rs114.592.0 124.5%  
Cash flow per share (Unadj.) Rs188.4110.0 171.3%  
Dividends per share (Unadj.) Rs25.004.00 625.0%  
Avg Dividend yield %0.60.6 99.2%  
Book value per share (Unadj.) Rs1,053.2374.3 281.4%  
Shares outstanding (eoy) m166.30585.94 28.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.71.6 232.5%   
Avg P/E ratio x37.37.4 506.0%  
P/CF ratio (eoy) x22.76.2 367.7%  
Price / Book Value ratio x4.11.8 223.8%  
Dividend payout %21.84.3 502.2%   
Avg Mkt Cap Rs m710,289397,398 178.7%   
No. of employees `000NANA-   
Total wages/salary Rs m36,29935,350 102.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m190,475247,746 76.9%  
Other income Rs m2,9143,809 76.5%   
Total revenues Rs m193,389251,555 76.9%   
Gross profit Rs m38,69981,480 47.5%  
Depreciation Rs m12,28810,554 116.4%   
Interest Rs m970745 130.2%   
Profit before tax Rs m28,35573,990 38.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,31920,098 46.4%   
Profit after tax Rs m19,03653,892 35.3%  
Gross profit margin %20.332.9 61.8%  
Effective tax rate %32.927.2 121.0%   
Net profit margin %10.021.8 45.9%  
BALANCE SHEET DATA
Current assets Rs m145,503198,235 73.4%   
Current liabilities Rs m81,038106,652 76.0%   
Net working cap to sales %33.837.0 91.6%  
Current ratio x1.81.9 96.6%  
Inventory Days Days6119 319.7%  
Debtors Days Days9552 184.3%  
Net fixed assets Rs m109,979135,778 81.0%   
Share capital Rs m832586 142.0%   
"Free" reserves Rs m174,319218,713 79.7%   
Net worth Rs m175,151219,299 79.9%   
Long term debt Rs m6,2991,684 374.0%   
Total assets Rs m255,482334,013 76.5%  
Interest coverage x30.2100.3 30.1%   
Debt to equity ratio x00 468.3%  
Sales to assets ratio x0.70.7 100.5%   
Return on assets %7.816.4 47.9%  
Return on equity %10.924.6 44.2%  
Return on capital %16.233.8 47.8%  
Exports to sales %51.353.8 95.4%   
Imports to sales %18.116.4 110.2%   
Exports (fob) Rs m97,699133,248 73.3%   
Imports (cif) Rs m34,42040,615 84.7%   
Fx inflow Rs m97,699133,248 73.3%   
Fx outflow Rs m34,42044,946 76.6%   
Net fx Rs m63,27988,302 71.7%   
CASH FLOW
From Operations Rs m35,70333,289 107.3%  
From Investments Rs m-22,6605,987 -378.5%  
From Financial Activity Rs m-298-13,648 2.2%  
Net Cashflow Rs m12,85825,831 49.8%  

Share Holding

Indian Promoters % 26.7 50.7 52.7%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 44.0 34.1 129.0%  
FIIs % 29.3 26.1 112.3%  
ADR/GDR % 14.0 0.0 -  
Free float % 59.2 46.2 128.2%  
Shareholders   131,498 128,210 102.6%  
Pledged promoter(s) holding % 0.0 22.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   HINDUSTAN BIOSCIE  PROCTER & GAMBLE HEALTH  ANG LIFESCIENCES INDIA  KILITCH DRUGS  FERMENTA BIOTECH  



Today's Market

Sensex Sheds 410 Points, Nifty Ends Below 17,750; Oil & Gas and Power Stocks Outperform(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended lower.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

A Great Time to Buy ITC(Profit Hunter)

Sep 17, 2021

Is the worst over for the stock of ITC?

Top Small Caps to Buy Now(Views On News)

Sep 18, 2021

Rahul Shah on why he would invest in these unusual 20 small cap stocks

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Sep 28, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS